Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indonesia Energy Corporation Limited (INDO) vs Invesco Ltd. (IVZ) Price & Performance

Indonesia Energy Corporation LimitedTrade
Invesco Ltd.Trade

Price performance (Past 24H)

Key statistics

Indonesia Energy Corporation Limited vs Invesco Ltd. — how do they compare? Indonesia Energy Corporation Limited trades at $2.74 (market cap $43.24M), while Invesco Ltd. trades at $29.51 (market cap $13.28B). The key difference: Invesco Ltd. is far larger — about 307.1× Indonesia Energy Corporation Limited's market cap, and Invesco Ltd. pays a 2.86% dividend while Indonesia Energy Corporation Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indonesia Energy Corporation Limited for 24 Days and Invesco Ltd. for 77 Days on average.

INDOIVZ
Market Cap
$43.24M$13.28B
Volume
116,9533,698,033
Sector
EnergyFinancials
52-Week High
$6.74$33.31
52-Week Low
$2.49$22.44
Typical Hold Time
24 Days77 Days
Enterprise Value
$38.18M$23.45B
Dividend Yield
—2.86%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indonesia Energy Corporation Limited

Indonesia Energy Corporation (INDO) trades at $2.81, up 1.44% with a bearish technical outlook despite 100% analyst buy ratings. The oil and gas explorer shows severe financial stress with negative margins (-152.7% net income margin) and consistent quarterly losses, though recent K-29 well discoveries offer operational catalysts. Cash flow remains dependent on financing activities as operations burn $5.43M annually.

High-risk speculative opportunity exists given the disconnect between negative fundamentals and optimistic analyst sentiment. Success hinges on new well production scaling revenue to achieve profitability. Key risks include execution delays, sustained cash burn, and oil price volatility that could threaten liquidity without additional financing.

Invesco Ltd.

IVZ trades at $30.09, down 1.34% on the day, with a bearish technical signal from moving averages and oscillators. The company reported a net loss of $281.70 million in 2025 despite revenue growth to $6.38 billion, though recent earnings beats in Q4 2025 and Q2 2026 show some operational resilience. Analyst consensus is mixed with a $33.14 price target, and the firm continues expanding its ETF suite, including the recent launch of the Invesco Nasdaq International Innovators 100 ETF.

The outlook remains cautious due to negative profitability margins and bearish technicals, but the absence of sell ratings and a dividend payment provide some support. Key risks include sustained negative net income and competitive pressures in the asset management sector, while potential upside hinges on improved earnings and AUM growth momentum.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDO
100% Buy0% Sell
Avg holding period · 24 Days
IVZ

No sentiment data available yet.

Top news

Latest headlines on both assets

About Indonesia Energy Corporation Limited

Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.

Read more on INDO →

About Invesco Ltd.

Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).

Read more on IVZ →